SARRECCHIA, CESARE
 Distribuzione geografica
Continente #
NA - Nord America 10.549
EU - Europa 902
AS - Asia 286
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
SA - Sud America 4
Totale 11.751
Nazione #
US - Stati Uniti d'America 10.546
IT - Italia 168
CN - Cina 144
UA - Ucraina 142
DE - Germania 123
FR - Francia 92
SE - Svezia 88
IE - Irlanda 87
PL - Polonia 85
SG - Singapore 82
FI - Finlandia 34
GB - Regno Unito 31
KR - Corea 30
RU - Federazione Russa 19
CZ - Repubblica Ceca 13
BE - Belgio 10
JP - Giappone 6
VN - Vietnam 6
AU - Australia 5
CH - Svizzera 5
HK - Hong Kong 5
IN - India 5
A2 - ???statistics.table.value.countryCode.A2??? 3
BR - Brasile 3
CA - Canada 2
EU - Europa 2
KG - Kirghizistan 2
BD - Bangladesh 1
CL - Cile 1
DK - Danimarca 1
DM - Dominica 1
EE - Estonia 1
MN - Mongolia 1
NL - Olanda 1
NO - Norvegia 1
NP - Nepal 1
SA - Arabia Saudita 1
TR - Turchia 1
TW - Taiwan 1
VA - Santa Sede (Città del Vaticano) 1
Totale 11.751
Città #
Woodbridge 3.207
Wilmington 2.823
Houston 2.497
Fairfield 364
Chandler 268
Ann Arbor 221
Ashburn 156
Seattle 137
Cambridge 116
Jacksonville 116
Kraków 85
Dublin 82
Rome 77
Medford 63
Dearborn 62
New York 61
Singapore 59
Zhengzhou 47
Beijing 41
Milan 33
Lawrence 29
Menlo Park 20
San Diego 18
Boardman 14
Palo Alto 14
San Francisco 13
Mülheim 12
Nanjing 11
Santa Clara 11
Shanghai 11
Brussels 10
Phoenix 10
Verona 10
Moscow 9
Creede 8
Falls Church 8
Munich 8
Brno 7
Dong Ket 6
Hefei 6
London 6
Olomouc 6
Helsinki 5
Kunming 5
Redwood City 5
University Park 5
Hong Kong 4
Nanchang 4
Auburn Hills 3
Chengdu 3
Colorado Springs 3
Guangzhou 3
Jinan 3
Lausanne 3
Mountain View 3
São Paulo 3
Arezzo 2
Bagnoregio 2
Binasco 2
Canberra 2
Engelhard 2
Fuzhou 2
Guiyang 2
Göttingen 2
Los Angeles 2
Monte Vista 2
Novokuznetsk 2
Redmond 2
Roebling 2
San Jose 2
Zurich 2
Amsterdam 1
Apo 1
Avellino 1
Bangalore 1
Baotou 1
Bari 1
Bobrynets 1
Buffalo 1
Cassino 1
Cedarhurst 1
Central 1
Chicago 1
Chieti 1
Chongqing 1
Council Bluffs 1
Dhaka 1
Gambettola 1
Indiana 1
Jaipur 1
Kathmandu 1
Kemerovo 1
L'aquila 1
La Canada Flintridge 1
Lake Forest 1
Melbourne 1
Montréal 1
North Hollywood 1
Norwalk 1
Nuremberg 1
Totale 10.873
Nome #
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 494
Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression 441
Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice 440
Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro 426
Granulocyte-macrophage colony-stimulating factor regulates cytokine production in cultured macrophages through CD14-dependent and -independent mechanisms. 423
Specific mutations in the C-terminus domain of HBV surface antigen significantly correlate with low level of serum HBV-DNA in patients with chronic HBV infection 423
Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance. 417
Characterization of drug-resistance mutations in HBV D-genotype chronically infected patients, naïve to antiviral drugs. 416
Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome 410
Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection. 408
Specific HbsAg genetic determinants are associated with occult HBV infection in vivo and HbsAg detection 407
HIV plasma viremia in 22 seropositive subjects [VALUTAZIONE DELLA VIREMIA PLASMATICA DA HIV IN 22 SOGGETTI SIERO-POSITIVI] 405
Detection of high levels of Survivin-immunoglobulin M immune complex in sera from hepatitis C virus infected patients with cirrhosis 403
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 402
HCV genotypes are differently prone to the development of resistance to linear and macrocyclic protease inhibitors 399
Multidrug resistance after lamivudine therapy for chronic hepatitis B 395
HBV reactivation with fatal fulminating hepatitis during rituximab treatment in a subject negative for HBsAg and positive for HBsAb and HBcAb 389
Optimal efficacy of interferon-free HCV retreatment after protease inhibitors failure in real life. 385
Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance 371
Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice. 369
Anti-HBV treatment induces novel reverse transcriptase mutations with reflective effect on HBV S antigen 365
Aciclovir, herpes viruses and HIV: a never-ending story 362
Late hepatitis B virus reactivation after lamivudine prophylaxis interruption in an anti-HBs-positive and anti-HBc-negative patient treated with rituximab-containing therapy 356
Two-year surveillance on fluconazole susceptibility of Candida spp isolates in a general and university hospital in Rome. 349
Novel reverse transcriptase mutations specifically associated with selected anti-Hbv treatment can induce alterations and stop-codons in Hbv S antigen 347
Interstitial pulmonary fibrosis in chronic HCV hepatitis treated with interferon 344
Long-term intramuscular teicoplanin treatment of chronic osteomyelitis due to oxacillin-resistant Staphylococcus aureus in outpatients 325
High rates of chronic HBV genotype E infection in a group of migrants in Italy from West Africa: Virological characteristics associated with poor immune clearance 320
Epidemiological burden estimates for pathologies with a non constant risk: an application to HCV in Italy according to age, Metavir score, and genotype 310
Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection 306
Impact of new DAA therapy on real clinical practice: A multicenter region-wide cohort study 233
Genetic signatures specifically clustered in immune active HBsAg regions correlate with immunosuppression-driven HBV reactivation: An extensive analysis of HBV genome. 20
Therapy and prevention of infective endocarditis 10
Totale 11.870
Categoria #
all - tutte 20.674
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.674


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.871 0 237 225 277 255 361 311 272 268 252 189 224
2020/20211.798 207 212 215 227 171 204 221 173 35 50 64 19
2021/2022441 24 36 36 22 4 32 21 13 103 33 15 102
2022/2023608 54 65 54 92 41 118 35 54 51 7 25 12
2023/2024200 31 2 11 4 6 66 0 14 4 8 0 54
2024/202594 24 70 0 0 0 0 0 0 0 0 0 0
Totale 11.870